442 related articles for article (PubMed ID: 16573830)
1. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
[TBL] [Abstract][Full Text] [Related]
2. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
3. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
4. [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K; Namura T; Murayama H; Arai S; Totani M; Ikemoto M
Rinsho Byori; 2009 Apr; 57(4):324-31. PubMed ID: 19489433
[TBL] [Abstract][Full Text] [Related]
5. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
6. Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptor gamma.
Ma L; Gao HQ; Li BY; Ma YB; You BA; Zhang FL
J Cardiovasc Pharmacol; 2007 May; 49(5):293-8. PubMed ID: 17513948
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
8. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
[TBL] [Abstract][Full Text] [Related]
9. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.
Ryckman C; McColl SR; Vandal K; de Médicis R; Lussier A; Poubelle PE; Tessier PA
Arthritis Rheum; 2003 Aug; 48(8):2310-20. PubMed ID: 12905486
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB.
Liu J; Zhao S; Tang J; Li Z; Zhong T; Liu Y; Chen D; Zhao M; Li Y; Gong X; Deng P; Wang JH; Jiang Y
FEBS J; 2009 Aug; 276(16):4598-606. PubMed ID: 19645720
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z
Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638
[TBL] [Abstract][Full Text] [Related]
12. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.
Basta G; Lazzerini G; Del Turco S; Ratto GM; Schmidt AM; De Caterina R
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1401-7. PubMed ID: 15845907
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro.
Talmor Y; Bernheim J; Klein O; Green J; Rashid G
Eur J Clin Invest; 2008 Aug; 38(8):548-54. PubMed ID: 18717824
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Wu JM; Ma YB; You BA; Li BY; Xuan JH
J Cardiovasc Pharmacol; 2006 Aug; 48(2):47-53. PubMed ID: 16954821
[TBL] [Abstract][Full Text] [Related]
15. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
Ho AW; Wong CK; Lam CW
Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701
[TBL] [Abstract][Full Text] [Related]
17. The response of the novel pro-inflammatory molecules S100A8/A9 to exercise.
Mooren FC; Lechtermann A; Fobker M; Brandt B; Sorg C; Völker K; Nacken W
Int J Sports Med; 2006 Sep; 27(9):751-8. PubMed ID: 16944403
[TBL] [Abstract][Full Text] [Related]
18. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
[TBL] [Abstract][Full Text] [Related]
19. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
20. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]